ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Antibody Response to SARS-CoV-2 Wanes Among Dialysis Patients
December 16, 2021For persons receiving dialysis, the antibody response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) wanes through five to six months and is associated with a risk for breakthrough infection... -
A protein-based COVID-19 vaccine that mimics the shape of the virus
August 13, 2021Even as several safe and effective COVID-19 vaccines are being administered to people worldwide, scientists are still hard at work developing different vaccine strategies that could provide even stronger or longer-lasting immunity against SARS-CoV-2 ... -
Our immune systems blanket the SARS-CoV-2 spike protein with antibodies
May 11, 2021The most complete picture yet is coming into focus of how antibodies produced in people who effectively fight off SARS-CoV-2 work to neutralize the part of the virus responsible for causing infection. In the journal Science, researchers at ... -
Axovant dumps nelotanserin in retreat from small molecule R&D
December 28, 2018Axovant has halted development of nelotanserin after it missed the primary endpoint in a phase 2 trial in patients with Lewy body dementia.....
Pharma Sources Insight January 2025
